Client News

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)

Medigene AG announces indication selection for the clinical development of its TCR-T therapy program in solid tumors

Abivax appoints Ana Sharma as Vice President, Global Head of Quality

Mainz Biomed Establishes Physician-led Laboratory Expanding Service Offering for Privately Insured Patients in Germany

Senta Brandt and Gerrick Rodrigues appointed to Global Leadership Positions at Rentschler Biopharma

AATec Medical starts collaboration with the German Federal Agency for Disruptive Innovation SPRIND for alpha-1 antitrypsin

Abivax announces update to obefazimod Phase 2b clinical development program in moderately to severely active Crohn’s disease

TVM Capital Life Science Announces €8 Million Investment in myo to Revolutionize Elderly Care via Innovative, Easy-to-Use App

Gedeon Richter becomes strategic investor of Formycon via equity investment

Affluent Medical closes €3.5 million bridge via capital increase from key shareholders